| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |